Nestle India and Dr. Reddy’s have officially inked a deal to establish a joint venture (JV), aiming to introduce cutting-edge nutraceutical brands to consumers in India and other designated regions.
Nestlé India and Dr. Reddy’s have entered into a definitive agreement to form JV Company, a joint venture to bring nutraceutical brands to consumers in India and other agreed territories.
The partnership will bring together a global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements of Nestlé Health Science with the commercial capabilities of Dr. Reddy’s in India.
An immunomodulatory drug, for the treatment of Multiple Myeloma (MM).
An extended-release tablet that belongs to a class of medication called beta-adrenergic blocker.
